CHAPEL HILL, N.C., May 26, 2011 /PRNewswire/ -- Medical Affairs serves as the linchpin for key new product planning activities that set the stage for a successful market entry of a new product.
Activities such as ad boards, KOL identification & management, clinical trial strategy & planning, and publication strategy & planning, are central to the new product planning process. They also represent the activities where organizations turn to Medical Affairs to play a lead role.
To give Medical Affairs leaders insights into the timing and value of these activities, Best Practices, LLC conducted research that produced the report "New Product Planning: Role and Activities for Medical Affairs." In addition to benchmarks that illustrate when organizations conduct Medical Affairs activities in the development cycle, the report provides narratives from new product planning veterans on how organizations approach these critical activities.
This 50-slide report provides drill down for each of these activities in terms of their timing, intended outcomes, and value for the organization:
To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1079.htm.
Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies. For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
|SOURCE Best Practices, LLC|
Copyright©2010 PR Newswire.
All rights reserved